Patents by Inventor Tae Heung KANG

Tae Heung KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING ANNEXIN V AND HPV TUMOR ANTIGEN FUSION POLYPEPTIDES AND METHODS FOR MAKING AND USE
    Publication number: 20230203104
    Abstract: The present invention provides synthetic polypeptides comprising an annexin V protein, or a functional portion or fragment or variant thereof, conjugated to a tumor antigen, or a functional portion or fragment or variant thereof. The invention further provides methods for making said synthetic polypeptides and their use in the treatment of proliferative diseases such as cancer and tumors originating therefrom.
    Type: Application
    Filed: August 2, 2019
    Publication date: June 29, 2023
    Inventors: Tzyy-Choou Wu, Chien-Fu Hung, Tae Heung Kang
  • Compositions for preventing or treating sepsis or septic shock compromising ADK protein as active ingredient
    Patent number: 10736944
    Abstract: The present invention relates to a composition for preventing or treating sepsis or septic shock including a Mycobacterium tuberculosis-derived adenosine kinase (ADK) protein as an active ingredient. The Mycobacterium tuberculosis-derived ADK protein according to one exemplary embodiment of the present invention has an effect of inhibit binding between the LPS and cells by binding to LPS, and also has an excellent therapeutic effect against sepsis by enhancing viability in a sepsis animal model and suppressing inflammatory response in the lung and cell death in the spleen.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: August 11, 2020
    Assignee: KONKUK UNIVERSITY GLOCAL INDUSTRY-ACADEMIC COLLABORATION FOUNDATION
    Inventors: Yeong Min Park, In Duk Jung, Sung Jae Shin, Jung Hee Park, Seung Jun Lee, Tae Heung Kang, Byoung Yul Soh
  • COMPOSITIONS FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING ADK PROTEIN AS ACTIVE INGREDIENT
    Publication number: 20190060418
    Abstract: The present invention relates to a composition for preventing or treating sepsis or septic shock including a Mycobacterium tuberculosis-derived adenosine kinase (ADK) protein as an active ingredient. The Mycobacterium tuberculosis-derived ADK protein according to one exemplary embodiment of the present invention has an effect of inhibit binding between the LPS and cells by binding to LPS, and also has an excellent therapeutic effect against sepsis by enhancing viability in a sepsis animal model and suppressing inflammatory response in the lung and cell death in the spleen.
    Type: Application
    Filed: September 4, 2018
    Publication date: February 28, 2019
    Inventors: Yeong Min PARK, In Duk JUNG, Sung Jae SHIN, Jung Hee PARK, Seung Jun LEE, Tae Heung KANG, Byoung Yul SOH
  • COMPOSITION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING ADK PROTEIN AS ACTIVE INGREDIENT
    Publication number: 20160263199
    Abstract: The present invention relates to a composition for preventing or treating sepsis or septic shock including a Mycobacterium tuberculosis-derived adenosine kinase (ADK) protein as an active ingredient. The Mycobacterium tuberculosis-derived ADK protein according to one exemplary embodiment of the present invention has an effect of inhibit binding between the LPS and cells by binding to LPS, and also has an excellent therapeutic effect against sepsis by enhancing viability in a sepsis animal model and suppressing inflammatory response in the lung and cell death in the spleen.
    Type: Application
    Filed: July 7, 2014
    Publication date: September 15, 2016
    Inventors: Yeong Min PARK, In Duk JUNG, Sung Jae SHIN, Jung Hee PARK, Seung Jun LEE, Tae Heung KANG, Byoung Yul SOH